Takeda Pharmaceutical (TAK) Times Interest Earned (2017 - 2026)

Takeda Pharmaceutical's Times Interest Earned history runs 10 years deep, the most recent figure standing at -$2.81 for Q1 2026.

• On a quarterly basis, Times Interest Earned fell 63.16% year-over-year to -$2.81 in Q1 2026; TTM through Mar 2026 was -$1.29, a 27.56% increase from a year earlier, with the FY2026 full-year figure at $0.04, down 97.43% from the prior year.
• Times Interest Earned slipped to -$2.81 in Q1 2026 per TAK's latest filing, from $7.66 in the prior quarter.
• Across five years, Times Interest Earned topped out at $7.66 in Q4 2025 and bottomed at -$2.83 in Q2 2023.
• The 5-year median for Times Interest Earned is -$2.22 (2025), against an average of -$1.32.
• Across the five-year window, Times Interest Earned plunged 452.92% in 2023 and surged 414.74% in 2025, its largest moves.
• Year by year, Times Interest Earned stood at -$1.84 in 2022, then grew by 2.3% to -$1.8 in 2023, then surged by 182.69% to $1.49 in 2024, then jumped by 414.74% to $7.66 in 2025, then plunged by 136.66% to -$2.81 in 2026.
• Per Business Quant, the three latest TAK Times Interest Earned figures stand at -$2.81 (Q1 2026), $7.66 (Q4 2025), and -$1.35 (Q3 2025).